RWM
RIGL icon

Ritholtz Wealth Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Ritholtz Wealth Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.12M Sell
78,386
-2,207
-3% -$74.2K 0.04% 365
2025
Q4 		$3.45M Buy
80,593
+72,999
+961% +$2.75M 0.06% 221
2025
Q3 		$215K Buy
+7,594
New +$227K ﹤0.01% 954

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ritholtz Wealth Management's RIGL Position: Q1 2026 in Review

Ritholtz Wealth Management reduced its Rigel Pharmaceuticals (RIGL) stake by 2.7% in Q1 2026, selling an estimated $74.2K and leaving 78,386 shares worth $2.12M. The position accounts for 0.04% of the portfolio, ranked #365.

Ritholtz Wealth Management first reported a position in RIGL in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.45M in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Ritholtz Wealth Management held 78,386 shares of Rigel Pharmaceuticals worth $2.12M as of Q1 2026.
  • Ritholtz Wealth Management sold 2,207 Rigel Pharmaceuticals shares in Q1 2026, an estimated $74.2K.
  • Rigel Pharmaceuticals made up 0.04% of Ritholtz Wealth Management's portfolio in Q1 2026, its #365 holding.
  • Ritholtz Wealth Management first reported a position in Rigel Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Ritholtz Wealth Management's Rigel Pharmaceuticals position peaked at $3.45M in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Ritholtz Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.